Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1968 Nov 9;4(5627):366–368. doi: 10.1136/bmj.4.5627.366

Dipyridamole: a Controlled Trial of its Effect in Acute Myocardial Infarction

A E Gent, C G D Brook, T H Foley, T N Miller
PMCID: PMC1912602  PMID: 4879059

Abstract

A controlled trial of oral dipyridamole in 103 patients with acute myocardial infarction showed no difference in the number of complications or deaths in either the control or the treated groups. It is concluded that dipyridamole has no benefit in acute myocardial infarction.

Full text

PDF
366

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BORN G. V., HASLAM R. J., GOLDMAN M. COMPARATIVE EFFECTIVENESS OF ADENOSINE ANALOGUES AS INHIBITORS OF BLOOD-PLATELET AGGREGATION AND AS VASODILATORS IN MAN. Nature. 1965 Feb 13;205:678–680. doi: 10.1038/205678a0. [DOI] [PubMed] [Google Scholar]
  2. BORN G. V., HONOUR A. J., MITCHELL J. R. INHIBITION BY ADENOSINE AND BY 2-CHLOROADENOSINE OF THE FORMATION AND EMBOLIZATION OF PLATELET THROMBI. Nature. 1964 May 23;202:761–765. doi: 10.1038/202761a0. [DOI] [PubMed] [Google Scholar]
  3. BUNAG R. D., DOUGLAS C. R., IMAI S., BERNE R. M. INFLUENCE OF A PYRIMIDOPYRIMIDINE DERIVATIVE ON DEAMINATION OF ADENOSINE BY BLOOD. Circ Res. 1964 Jul;15:83–88. doi: 10.1161/01.res.15.1.83. [DOI] [PubMed] [Google Scholar]
  4. CLARKE D. A., DAVOLL J., PHILIPS F. S., BROWN G. B. Enzymatic deamination and vasodepressor effects of adenosine analogs. J Pharmacol Exp Ther. 1952 Nov;106(3):291–302. [PubMed] [Google Scholar]
  5. DAHL M., KASANEN A., PELTONEN T. The effect of Segontin, Persantin and nitroglycerin on the coronary artery. Experimental studies with cinecoronarography. Ann Med Exp Biol Fenn. 1962;40:423–426. [PubMed] [Google Scholar]
  6. Emmons P. R., Harrison M. J., Honour A. J., Mitchell J. R. Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit. Nature. 1965 Oct 16;208(5007):255–257. doi: 10.1038/208255a0. [DOI] [PubMed] [Google Scholar]
  7. Emmons P. R., Harrison M. J., Honour A. J., Mitchell J. R. Effect of dipyridamole on human platelet behaviour. Lancet. 1965 Sep 25;2(7413):603–606. doi: 10.1016/s0140-6736(65)90515-5. [DOI] [PubMed] [Google Scholar]
  8. FAM W. M., MCGREGOR M. EFFECT OF CORONARY VASODILATOR DRUGS ON RETROGRADE FLOW IN AREAS OF CHRONIC MYOCARDIAL ISCHEMIA. Circ Res. 1964 Oct;15:355–364. doi: 10.1161/01.res.15.4.355. [DOI] [PubMed] [Google Scholar]
  9. GRIEP A. H. A LONG-TERM THERAPY OF ISCHEMIC HEART DISEASE. Angiology. 1963 Sep;14:484–489. doi: 10.1177/000331976301400909. [DOI] [PubMed] [Google Scholar]
  10. Gaddy C. G. Dipyridamole in long-term treatment of coronary insufficiency. Va Med Mon (1918) 1966 Jun;93(6):336–339. [PubMed] [Google Scholar]
  11. LEIBERMAN A., GUGLIELMELLI S. PERSANTIN-- A DOUBLE BLIND STUDY. Angiology. 1964 Jun;15:290–292. doi: 10.1177/000331976401500608. [DOI] [PubMed] [Google Scholar]
  12. NEWHOUSE M. T., MCGREGOR M. LONG TERM DIPYRIDAMOLE THERAPY OF ANGINA PECTORIS. Am J Cardiol. 1965 Aug;16:234–237. doi: 10.1016/0002-9149(65)90478-9. [DOI] [PubMed] [Google Scholar]
  13. Rees J. R., Redding V. J. Effects of dipyridamole on anastomotic blood flow in experimental myocardial infarction. Cardiovasc Res. 1967 Apr;1(2):179–183. doi: 10.1093/cvr/1.2.179. [DOI] [PubMed] [Google Scholar]
  14. Sbar S., Schlant R. C. Dipyridamole in the treatment of angina pectoris. A double-blind evaluation. JAMA. 1967 Sep 11;201(11):865–867. [PubMed] [Google Scholar]
  15. VINEBERG A. M., CHARI R. S., PIFARRE R., MERCIER C. [Effect of persantin on intercoronary collateral circulation and on survival obtained during progressive coronary occlusion in in animals. Preliminary report]. Union Med Can. 1962 Oct;91:1068–1079. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES